Phenotypes List
This page documents all named alleles, phenotypes and activity scores used by PharmCAT.
Download as .tsv
If you are using outside calls, you can see how well PharmCAT will be able to annotate your data by checking if your names align with ours.
ABCG2
Named Variants | CPIC Phenotypes | DPWG Phenotypes |
- rs2231142 reference (G)
- rs2231142 variant (T)
| - Decreased Function
- Normal Function
- Poor Function
| - Decreased Function
- Normal Function
- Poor Function
|
CACNA1S
Named Variants | CPIC Phenotypes |
- Reference
- c.520C>T
- c.3257G>A
| - Malignant Hyperthermia Susceptibility
- Uncertain Susceptibility
|
CFTR
Named Variants | CPIC Phenotypes |
- 711+3A->G
- 2789+5G->A
- 3272-26A->G
- 3849+10kbC->T
- A455E
- A1067T
- D110E
- D110H
- D579G
- D1152H
- D1270N
- E56K
- E193K
- E831X
- F1052V
- F1074L
- G178R
- G551D
- G551S
- G1069R
- G1244E
- G1349D
- K1060T
- L206W
- P67L
- R74W
- R117C
- R117H
- R347H
- R352Q
- R1070Q
- R1070W
- S549N
- S549R(A>C)
- S549R(T>G)
- S945L
- S977F
- S1251N
- S1255P
- ivacaftor non-responsive CFTR sequence
| - ivacaftor non-responsive in CF patients
- ivacaftor responsive in CF patients
|
CYP2B6
Named Alleles | CPIC Phenotypes | DPWG Phenotypes |
- *1
- *2
- *3
- *4
- *5
- *6
- *7
- *8
- *9
- *10
- *11
- *12
- *13
- *14
- *15
- *17
- *18
- *19
- *20
- *21
- *22
- *23
- *24
- *25
- *26
- *27
- *28
- *31
- *32
- *33
- *34
- *35
- *36
- *37
- *38
- *39
- *40
- *41
- *42
- *43
- *44
- *45
- *46
- *47
- *48
- *49
| - Indeterminate
- Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
- Rapid Metabolizer
- Ultrarapid Metabolizer
| - Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
|
CYP2C19
Named Alleles | CPIC Phenotypes | DPWG Phenotypes |
- *1
- *2
- *3
- *4
- *5
- *6
- *7
- *8
- *9
- *10
- *11
- *12
- *13
- *14
- *15
- *16
- *17
- *18
- *19
- *22
- *23
- *24
- *25
- *26
- *28
- *29
- *30
- *31
- *32
- *33
- *34
- *35
- *38
- *39
| - Indeterminate
- Intermediate Metabolizer
- Likely Intermediate Metabolizer
- Likely Poor Metabolizer
- Normal Metabolizer
- Poor Metabolizer
- Rapid Metabolizer
- Ultrarapid Metabolizer
| - Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
- Ultrarapid Metabolizer
|
CYP2C9
Named Alleles | CPIC Phenotypes | CPIC Activity Scores | DPWG Phenotypes |
- *1
- *2
- *3
- *4
- *5
- *6
- *7
- *8
- *9
- *10
- *11
- *12
- *13
- *14
- *15
- *16
- *17
- *18
- *19
- *20
- *21
- *22
- *23
- *24
- *25
- *26
- *27
- *28
- *29
- *30
- *31
- *32
- *33
- *34
- *35
- *36
- *37
- *38
- *39
- *40
- *41
- *42
- *43
- *44
- *45
- *46
- *47
- *48
- *49
- *50
- *51
- *52
- *53
- *54
- *55
- *56
- *57
- *58
- *59
- *60
- *61
- *62
- *63
- *64
- *65
- *66
- *67
- *68
- *69
- *70
- *71
- *72
- *73
- *74
- *75
- *76
- *77
- *78
- *79
- *80
- *81
- *82
- *83
- *84
- *85
| - Indeterminate
- Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
| | - Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
|
CYP2D6
CYP3A4
Named Alleles | DPWG Phenotypes |
- *1
- *2
- *3
- *4
- *5
- *6
- *7
- *8
- *9
- *10
- *11
- *12
- *13
- *14
- *15
- *16
- *17
- *18
- *19
- *20
- *21
- *22
- *23
- *24
- *26
- *28
- *29
- *30
- *31
- *32
- *33
- *34
- *35
- *37
- *38
- *39
- *40
- *41
- *42
- *43
- *44
- *45
- *46
- *47
- *48
| - Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
|
CYP3A5
Named Alleles | CPIC Phenotypes | DPWG Phenotypes |
| - Indeterminate
- Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
- Possible Intermediate Metabolizer
| - Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
|
CYP4F2
No recommendations available for this gene.
Named Alleles |
- *1
- *2
- *3
- *4
- *5
- *6
- *7
- *8
- *9
- *10
- *11
- *12
- *13
- *14
- *15
- *17
|
DPYD
Named Variants | CPIC Phenotypes | CPIC Activity Scores | DPWG Phenotypes |
- Reference
- c.46C>G
- c.61C>T
- c.62G>A
- c.85T>C (*9A)
- c.295_298delTCAT (*7)
- c.313G>A
- c.343A>G
- c.451A>G
- c.496A>G
- c.498G>A
- c.525G>A
- c.557A>G
- c.601A>C
- c.632A>G
- c.703C>T (*8)
- c.775A>G
- c.868A>G
- c.929T>C
- c.934C>T
- c.967G>A
- c.1003G>T (*11)
- c.1024G>A
- c.1057C>T
- c.1108A>G
- c.1129-5923C>G
- c.1129-5923C>G, c.1236G>A (HapB3)
- c.1156G>T (*12)
- c.1180C>T
- c.1181G>T
- c.1218G>A
- c.1260T>A
- c.1278G>T
- c.1294G>A
- c.1314T>G
- c.1349C>T
- c.1358C>G
- c.1371C>T
- c.1403C>A
- c.1475C>T
- c.1484A>G
- c.1519G>A
- c.1543G>A
- c.1577C>G
- c.1601G>A (*4)
- c.1615G>A
- c.1627A>G (*5)
- c.1679T>G (*13)
- c.1682G>T
- c.1774C>T
- c.1775G>A
- c.1777G>A
- c.1796T>C
- c.1896T>C
- c.1898delC (*3)
- c.1905+1G>A (*2A)
- c.1905C>G
- c.1906A>C
- c.1990G>T
- c.2021G>A
- c.2161G>A
- c.2186C>T
- c.2194G>A (*6)
- c.2195T>G
- c.2279C>T
- c.2303C>A
- c.2336C>A
- c.2482G>A
- c.2582A>G
- c.2623A>C
- c.2639G>T
- c.2656C>T
- c.2657G>A (*9B)
- c.2846A>T
- c.2872A>G
- c.2915A>G
- c.2921A>T
- c.2933A>G
- c.2977C>T
- c.2978T>G
- c.2983G>T (*10)
- c.3049G>A
- c.3061G>C
- c.3067C>A
| - Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
| | - 0.0 (Poor Metabolizer)
- 0.5 (Phenotyping)
- 1.0 (Intermediate Metabolizer)
- 1.0 (Phenotyping)
- 1.5 (Intermediate Metabolizer)
- 2.0 (Normal Metabolizer)
|
G6PD
Named Variants | CPIC Phenotypes |
- 202G>A_376A>G_1264C>G
- A
- A- 202A_376G
- A- 680T_376G
- A- 968C_376G
- Aachen
- Abeno
- Acrokorinthos
- Alhambra
- Amazonia
- Amiens
- Amsterdam
- Anadia
- Ananindeua
- Andalus
- Arakawa
- Asahi
- Asahikawa
- Aures
- Aveiro
- B (reference)
- Bajo Maumere
- Bangkok
- Bangkok Noi
- Bao Loc
- Bari
- Belem
- Beverly Hills, Genova, Iwate, Niigata, Yamaguchi
- Brighton
- Buenos Aires
- Cairo
- Calvo Mackenna
- Campinas
- Canton, Taiwan-Hakka, Gifu-like, Agrigento-like
- Cassano
- Chatham
- Chikugo
- Chinese-1
- Chinese-5
- Cincinnati
- Cleveland Corum
- Clinic
- Coimbra Shunde
- Cosenza
- Costanzo
- Covao do Lobo
- Crispim
- Dagua
- Durham
- Farroupilha
- Figuera da Foz
- Flores
- Fukaya
- Fushan
- Gaohe
- Georgia
- Gidra
- Gond
- Guadalajara
- Guangzhou
- Haikou
- Hammersmith
- Harilaou
- Harima
- Hartford
- Hechi
- Hermoupolis
- Honiara
- Ierapetra
- Ilesha
- Insuli
- Iowa, Walter Reed, Springfield
- Iwatsuki
- Japan, Shinagawa
- Kaiping, Anant, Dhon, Sapporo-like, Wosera
- Kalyan-Kerala, Jamnaga, Rohini
- Kambos
- Kamiube, Keelung
- Kamogawa
- Kawasaki
- Kozukata
- Krakow
- La Jolla
- Lages
- Lagosanto
- Laibin
- Lille
- Liuzhou
- Loma Linda
- Ludhiana
- Lynwood
- Madrid
- Mahidol
- Malaga
- Manhattan
- Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham
- Metaponto
- Mexico City
- Miaoli
- Minnesota, Marion, Gastonia, LeJeune
- Mira d'Aire
- Mizushima
- Montalbano
- Montpellier
- Mt Sinai
- Munich
- Murcia Oristano
- Musashino
- Namouru
- Nankang
- Nanning
- Naone
- Nara
- Nashville, Anaheim, Portici
- Neapolis
- Nice
- Nilgiri
- No name
- North Dallas
- Olomouc
- Omiya
- Orissa
- Osaka
- Palestrina
- Papua
- Partenope
- Pawnee
- Pedoplis-Ckaro
- Piotrkow
- Plymouth
- Praha
- Puerto Limon
- Quing Yan
- Radlowo
- Rehevot
- Rignano
- Riley
- Riverside
- Roubaix
- S. Antioco
- Salerno Pyrgos
- Santa Maria
- Santiago
- Santiago de Cuba, Morioka
- Sao Borja
- Seattle, Lodi, Modena, Ferrara II, Athens-like
- Seoul
- Serres
- Shenzen
- Shinshu
- Sibari
- Sierra Leone
- Sinnai
- Songklanagarind
- Split
- Stonybrook
- Sugao
- Sumare
- Sunderland
- Surabaya
- Suwalki
- Swansea
- Taipei, Chinese-3
- Telti, Kobe
- Tenri
- Tokyo, Fukushima
- Toledo
- Tomah
- Tondela
- Torun
- Tsukui
- Ube Konan
- Union,Maewo, Chinese-2, Kalo
- Urayasu
- Utrecht
- Valladolid
- Vancouver
- Vanua Lava
- Viangchan, Jammu
- Volendam
- Wayne
- West Virginia
- Wexham
- Wisconsin
- Yunan
| - Deficient
- Deficient with CNSHA
- Indeterminate
- Normal
- Variable
|
IFNL3
No recommendations available for this gene.
Named Alleles |
- rs12979860 reference (C)
- rs12979860 variant (T)
|
MT-RNR1
Named Variants | CPIC Phenotypes |
- Reference
- m.663A>G
- m.669T>C
- m.747A>G
- m.786G>A
- m.807A>C
- m.807A>G
- m.827A>G
- m.839A>G
- m.896A>G
- m.930A>G
- m.951G>A
- m.960C>del
- m.961T>G
- m.961T>del
- m.961T>del+Cn
- m.988G>A
- m.1095T>C
- m.1189T>C
- m.1243T>C
- m.1494C>T
- m.1520T>C
- m.1537C>T
- m.1555A>G
- m.1556C>T
| - increased risk of aminoglycoside-induced hearing loss
- normal risk of aminoglycoside-induced hearing loss
- uncertain risk of aminoglycoside-induced hearing loss
|
NUDT15
Named Alleles | CPIC Phenotypes | DPWG Phenotypes |
- *1
- *2
- *3
- *4
- *5
- *6
- *7
- *8
- *9
- *10
- *11
- *12
- *13
- *14
- *15
- *16
- *17
- *18
- *19
- *20
| - Indeterminate
- Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
- Possible Intermediate Metabolizer
| - Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
|
RYR1
SLCO1B1
Named Alleles | CPIC Phenotypes | DPWG Phenotypes |
- *1
- *2
- *3
- *4
- *5
- *6
- *7
- *8
- *9
- *10
- *11
- *12
- *13
- *14
- *15
- *16
- *19
- *20
- *23
- *24
- *25
- *26
- *27
- *28
- *29
- *30
- *31
- *32
- *33
- *34
- *36
- *37
- *38
- *39
- *40
- *41
- *42
- *43
- *44
- *45
- *46
- *47
| - Decreased Function
- Increased Function
- Indeterminate
- Normal Function
- Poor Function
- Possible Decreased Function
| - Decreased Function
- Normal Function
- Poor Function
|
TPMT
Named Alleles | CPIC Phenotypes | DPWG Phenotypes |
- *1
- *2
- *3A
- *3B
- *3C
- *4
- *5
- *6
- *7
- *8
- *9
- *10
- *11
- *12
- *13
- *14
- *15
- *16
- *17
- *18
- *19
- *20
- *21
- *22
- *23
- *24
- *25
- *26
- *27
- *28
- *29
- *30
- *31
- *32
- *33
- *34
- *35
- *36
- *37
- *38
- *39
- *40
- *41
- *42
- *43
- *44
| - Indeterminate
- Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
- Possible Intermediate Metabolizer
| - Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
|
UGT1A1
Named Alleles | CPIC Phenotypes | DPWG Phenotypes |
- *1
- *6
- *27
- *28
- *36
- *37
- *80
- *80+*28
- *80+*37
| - Indeterminate
- Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
| - Intermediate Metabolizer
- Normal Metabolizer
- Poor Metabolizer
|
VKORC1
Named Variants | DPWG Phenotypes |
- rs9923231 reference (C)
- rs9923231 variant (T)
| - -1639 AA
- -1639 AG
- -1639 GG
|
Allele Presence Genes
PharmCAT provides recommendations for these genes based on the presence or absence of specific named alleles.
HLA-A
HLA-B